There are around 550 bone marrow transplants done in the country annually, but we have a bottleneck in allogeneic transplants, and we are well behind where…
In Conversation
In essence, the market access system has progressed in terms of consolidation, but there is a call for it to become more data-driven and collaborative in…
The regulation surrounding cannabis in Portugal has become notably favourable, creating a conducive environment for exploration in this sector
The strategic move to more complex developments and the emphasis on disruptive and innovative areas showcase Tecnimede's commitment to staying at the forefront of pharmaceutical advancements
The difficulties faced by the generic and biosimilar pharmaceutical industry and the economic unsustainability of many of its medicines are reflected in the high number of…
Despite our size, Servier Portugal has a significant impact and contribution to the company's global value
The focus on top-tier research in Portugal has the potential to drive technology transfer from the academic lab to commercial success
Organon took a portfolio of more than 60 products, 9,000+ employees and over USD 6 billion in revenue; it is a large and complex organization that…
It is hard to find any procedure in a hospital where one single product from B. Braun is not present
"Consequently, we increased production output from 4,000,000 units to roughly 100,000,000. For a small company, this is a vast increase regarding production."
“Our affiliate tripled its activity in R&D in last 3 years: going from 8 studies in 2015 to 18 in 2018 and we have also increased…
"We are already working with the National Health Service in the South of Portugal, but also in Australia, and several players in the US whom share…
